Trial Profile
Single and Multiple Dose Pharmacokinetics and Pharmacodynamics of Prasugrel (LY640315) in Korean Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Acute coronary syndromes; Embolism and thrombosis
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 10 May 2012 New trial record